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ABSTRACT
Background: Whether smokers and former smokers have worse lipid proﬁles or glucose levels than non-smokers
remains unclear.
Methods: The subjects were 1152 Japanese males aged 42 to 81 years. The subjects were divided according to their
smoking habits (nonsmokers, former smokers, and current smokers) and their visceral fat area (VFA) (<100 cm2 and
≥100 cm2).
Results: The serum triglyceride (TG) levels of 835 males were assessed. In the VFA ≥100 cm2 group, a signiﬁcantly
greater proportion of current smokers (47.3%) exhibited TG levels of ≥150mg/dL compared with former smokers
(36.4%) and non-smokers (18.8%). The difference in TG level distribution between former smokers and non-smokers
was also signiﬁcant. However, among the subjects with VFA of <100 cm2, the TG levels of the three smoking habit
groups did not differ. The serum hemoglobin A1c (HbA1c) levels of 877 males were also assessed. In the VFA
<100 cm2 group, signiﬁcantly higher proportions of current smokers (17.9%) and former smokers (14.9%)
demonstrated HbA1c levels of ≥5.6% compared with non-smokers (6.3%). In contrast, in the VFA ≥100 cm2 group,
signiﬁcantly fewer former smokers displayed HbA1c levels of ≥5.6% compared with non-smokers and current
smokers. Furthermore, the interaction between smoking habits and VFA was associated with the subjects’ TG and
HbA1c concentrations, and the associations of TG and HbA1c concentrations and smoking habits varied according to
VFA.
Conclusions: Both smoking habits and VFA exhibited associations with TG and HbA1c concentrations. The
associations between smoking habits and these parameters differed according to VFA.
Key words: smoking habits; visceral fat; interaction; serum triglycerides; hemoglobin A1c
INTRODUCTION
Smoking is a known risk factor for arteriosclerosis and
diabetes mellitus (DM). Previous studies have reported that
smokers have higher serum triglyceride (TG) and blood
glucose concentrations and lower high-density lipoprotein
cholesterol (HDL-C) concentrations than non-smokers.1–6
However, ﬁndings regarding whether smokers and former
smokers have worse lipid proﬁles or glucose levels than
non-smokers have been inconsistent. Freeman et al reported
that smoking has little impact on TG levels in males.3 In
addition, several studies have demonstrated that the insulin
resistance and fasting serum glucose levels of current smokers
and non-smokers do not differ signiﬁcantly,7–10 and light
smoking was found to reduce the risk of type 2 DM in lean
males.11
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Differences in weight or fat distribution might have been
responsible for the inconsistent results obtained by previous
studies. Body weight and abdominal visceral fat (VF)
volume are strongly associated with higher serum TG
concentrations,12,13 lower serum HDL-C concentrations,14
and insulin resistance.15–17 In addition, smoking and/or
smoking cessation might affect body weight and fat
distribution. For example, many studies have indicated that
smokers tend to have lower body weights than non-
smokers,18–20 and smoking cessation is known to be
associated with substantial weight gain.20–22 It is also known
that smoking is a risk factor for abdominal VF
accumulation.19,23 Thus, the relationships among smoking,
body weight, VF, serum lipids, and serum glucose levels
are complex. Some previous studies have analyzed the
associations of the interaction between smoking and body
mass index (BMI) and lipid or glucose metabolism.11,24,25
However, BMI is not necessarily an accurate measure of VF
accumulation, as it is inﬂuenced by both adipose and lean
tissue.
Therefore, the purpose of this study was to investigate the
interaction between smoking habits and VF area (VFA),
which was measured using computerized tomography (CT)
scans, and serum lipid (Study 1) or serum glucose (Study 2)
concentrations.
METHODS
Subjects
The subjects were selected from among the 1152 Japanese
males (age range, 40 to 82 years) who participated in the
second wave of the National Institute for Longevity Sciences-
Longitudinal Study of Aging (NIL-LSA; the second wave
examinations were conducted from April 2000 to May 2002).
The NIL-LSA involved gender- and age-stratiﬁed samples
that were randomly selected from the local neighborhood
surrounding our institute. The purpose of the present study
was explained to each subject before written consent was
obtained. The design of the NILS-LSA has been described
elsewhere.26 Subjects who had eaten breakfast were excluded.
The smoking data and medical history of the subjects,
including any medication and/or treatment that they had
received, were self-reported by the subjects using a
questionnaire. Non-smokers were deﬁned as people that had
never smoked. Former smokers were deﬁned as those who
had quit smoking more than 1 year ago and had not smoked
since, and current smokers were deﬁned as those who had
been smoking for more than 1 year. The subjects of Study 1
were 835 males (72% of the NIL-LSA cohort) who did not
have a medical history of dyslipidemia and were not taking
medication for the condition. The subjects of Study 2 were
877 males (76% of the NIL-LSA cohort) who did not have a
medical history of DM and were not taking medication for
the condition (Figure 1).
Measurements
The subjects had their body weight (kg) assessed in the
morning after overnight fasting. Body weight was measured
using digital scales with the subjects only wearing underwear.
BMI was calculated as weight (kg) divided by height (m)
squared. VFA (cm2) and subcutaneous fat area (SFA; cm2)
were measured using CT scans of the abdomen taken at
the umbilical level (L4–L5). All CT scans (SCT-6800TX;
Shimadzu, Osaka, Japan) were performed with the subjects
in the supine position. VFA and SFA were calculated using
computer software (Fat Scan; N2 Systems, Osaka, Japan)27 in
accordance with a previously described procedure.28
Venous blood was collected in tubes containing
ethylenediaminetetraacetic acid (EDTA, disodium salt,
50mM) after overnight fasting, and then the samples’ serum
total cholesterol (TC; mg/dL), HDL-C (mg/dL), TG (mg/dL),
glucose (mg/dL), and hemoglobin A1c (HbA1c) (%) levels
were analyzed. In this study, the HbA1c data are given in
Japan Diabetes Society (JDS) units, which are calculated by
subtracting 0.4 from standard HbA1c values.29
Dietary intake was estimated from 3-day food records,
which were accompanied by before and after photos of
each meal.30 Dietitians checked the food records while
examining the photos. Physical activity was estimated from
interviews regarding the subjects’ physical activity in the past
year.31
Data analysis
The subjects were divided into three groups (non-smokers,
former smokers, and current smokers) based on the results of
the smoking habits questionnaire. In addition, the subjects
were also grouped into two VFA categories (VFA <100 cm2
and VFA ≥100 cm2), which were chosen based on the criterion
for visceral obesity developed by the Japanese Society of
Obesity.32 Comparisons of means among the smoking habit
and VFA groups were performed using the Steel-Dwass test.
Two-way ANOVA was used to evaluate the effects of the
interaction between VFA categories and smoking habits on the
subjects’ serum concentrations of TG, HDL-C, TC, glucose,
and HbA1c. Prior to the analysis, the subjects’ HDL-C, TG,
fasting glucose, and HbA1c concentrations were converted to
natural logarithms (ln) to normalize their skewed distributions.
Comparisons between frequencies were performed using chi-
squared test. In Study 1, the following criteria were used to
diagnose dyslipidemia: TC ≥220mg/dL, HDL-C <40mg/dL,
and TG ≥150mg/dL. These criteria were developed by the
Japan Atherosclerosis Society.33 In Study 2, the following
criteria were employed to diagnose metabolic syndrome:
fasting glucose ≥110mg/dL and HbA1c (JDS) ≥5.6%. The
former criteria were developed by the Japan Society of
Obesity,32 and the latter criteria were used as a substitute
for fasting glucose in the National Health and Nutrition
Examination Survey.34 Probability values of less than 0.05
were regarded as signiﬁcant. The data were analyzed using the
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SAS statistical software package (release 9.3; SAS Institute,
Cary, NC, USA).
Ethics
This study was performed in accordance with the World
Medical Association Declaration of Helsinki—Ethical
Principles for Medical Research Involving Human Subjects.
All of the procedures performed in the NILS-LSA were
approved by the Committee of Ethics for Human Research at
the National Center for Geriatrics and Gerontology. In the
NILS-LSA study, an explanatory meeting was held 2 weeks
before the start of the examinations.26 At the meeting, the
purpose of the study and the procedures for each examination
were fully explained to the subjects. All of the participants
provided written informed consent. All data were analyzed
collectively, and the subjects’ privacy was protected.
RESULTS
Study 1
The characteristics of subjects in Study 1 are shown in
Table 1. Compared with non-smokers (22.8%) and current
smokers (30.0%), a signiﬁcantly greater proportion of former
smokers (47.2%) exhibited VFA ≥100 cm2 (P < 0.01). In the
VFA ≥100 cm2 group, non-smokers had the lowest mean
serum TG concentration (P < 0.01), and that of former
smokers was signiﬁcantly lower than that of current
smokers (P < 0.01). Among subjects with VFA <100 cm2,
the serum TG levels of the three smoking habit groups did
not differ, but current smokers had a signiﬁcantly lower
mean serum HDL-C concentration than former smokers
(P < 0.05). In the VFA ≥100 cm2 group, the mean serum
HDL-C concentration of current smokers was signiﬁcantly
lower than that of non-smokers (P < 0.01). The mean serum
TC concentrations of the three smoking habit groups did
not differ in either the VFA <100 cm2 or VFA ≥100 cm2
groups. Similarly, energy intake and physical activity did not
differ among the three smoking habit groups in either the
VFA <100 cm2 or VFA ≥100 cm2 group. Current smokers
consumed more alcohol than the other groups.
Figure 2 shows the prevalence of elevated serum TC and
TG levels and lower serum HDL-C concentrations. In the
VFA ≥100 cm2 group, a signiﬁcantly higher proportion
of current smokers (47.3%) exhibited serum TG levels
Males aged 40-82 years who 
participated in the 2nd wave 
of the NILS-LSA      
(n=1,152)
Visceral fat area measured, 
blood collected, and
questionnaire performed
(n=1,076)
n=1,040
Ate breakfast  (n=36)
Full dataset 
available 
(n=1,032)
n=873
Full dataset 
available
(n=1,031)
n=917
<Study 1: Lipids> <Study 2: Glucose>
Missing 
measurements
(n=8)
Missing 
measurements
(n=9)
Took medication 
for or had a 
medical history of 
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(n=159)
Took medication for
or had a medical 
history of diabetes 
mellitus (n=114)
n=1,040n=1,040
n=835 n=877
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smoking within 1 
year (n=38)
Quit or started 
smoking within 1 
year (n=40)
Figure 1. Sampling procedure.
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≥150mg/dL compared with former smokers (36.4%) and non-
smokers (18.8%). In the VFA <100 cm2 group, there was no
difference in the frequency of serum TG levels ≥150mg/dL
among the three smoking habit groups. The frequency of
serum HDL-C levels <40mg/dL was highest in current
smokers in both the VFA <100 cm2 (current smokers: 9.7%,
former smokers: 3.6%, non-smokers: 2.3%) and VFA
≥100 cm2 groups (current smokers: 17.6%, former smokers:
7.0%, non-smokers: 5.8%).
Two-way ANCOVA demonstrated that the interaction
between VFA and smoking habits was signiﬁcantly
associated with the serum ln(TG) level but not serum ln(TC)
or ln(HDL-C) levels (Table 2).
Study 2
The characteristics of subjects in Study 2 are shown in
Table 3. Compared with non-smokers (33.3%) and current
smokers (35.5), a signiﬁcantly greater proportion of former
smokers (43.9%) had VFA ≥100 cm2 (P < 0.05). Non-smokers
exhibited a signiﬁcantly lower mean serum HbA1c level than
Table 1. Characteristics of Study 1 subjects according to their smoking habits
All
n = 835
VFA <100 cm2 VFA ≥100 cm2
Non-smokers Former smokers Current smokers Non-smokers Former smokers Current smokers
n = 132 n = 193 n = 207 n = 69 n = 143 n = 91
Age, years 60.5 (10.8) 58.7 (11.1) 61.9 (11.2)** 58.7 (10.5)†† 61.5 (9.4) 63.2 (10.4) 59.0 (10.3)††
BMI, kg/m2 22.9 (2.8) 21.9 (2.3) 21.9 (2.4) 21.3 (2.3)*† 25.1 (2.1) 25.0 (2.4) 24.8 (2.4)
VFA, cm2 90.2 (49.8) 57.9 (24.9) 61.9 (24.5) 59.9 (25.5) 137.8 (30.6) 144.4 (40.7) 144.4 (35.8)
Subcutaneous fat area, cm2 109.0 (47.7) 96.2 (38.6) 96.1 (39.9) 86.9 (40.6)*† 140.1 (49.8) 142.4 (44.4) 128.6 (46.3)†
Physical activity, METS*min/yr/103 701 (876) 709 (88) 700 (90) 713 (98) 701 (71) 680 (70) 691 (82)
Total cholesterol, mg/dL 207.1 (32.7) 208.1 (33.0) 206.3 (34.6) 204.3 (32.3) 211.5 (33.9) 210.2 (29.9) 205.3 (32.1)
HDL cholesterol, mg/dL 57.9 (14.9) 61.7 (13.5) 62.4 (16.3) 58.7 (16.1)† 56.5 (13.3) 52.6 (11.0)* 50.8 (12.0)**
Triglycerides, mg/dL 120.6 (71.2) 110.9 (53.7) 101.8 (48.0) 112.0 (63.1) 111.4 (39.9) 143.3 (78.5)** 179.8 (109.3)**††
n = 777 n = 125 n = 180 n = 190 n = 64 n = 135 n = 83
Energy intake, kcal 2301 (411) 2318 (414) 2308 (379) 2270 (408) 2288 (443) 2279 (387) 2379 (489)
Alcohol intake, g/day 16.5 (20.3) 15.9 (19.0) 15.9 (19.2)* 18.6 (23.0)** 12.6 (15.7) 14.3 (15.9) 27.8 (27.4)**††
BMI, body mass index; HDL, high-density lipoprotein; METS, metabolic equivalents; VFA, visceral fat area.
Data are shown as mean (standard deviation) values.
The differences between groups were analyzed using the Steel-Dwass test.
P-values: Compared with non-smokers: *P < 0.05, **P < 0.01; Compared with former smokers: †P < 0.05, ††P < 0.01.
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Figure 2. Frequencies of high serum total cholesterol
and triglyceride levels and low serum HDL
cholesterol concentrations.
Table 2. Two-way factorial ANOVA
F-value P-value
Study 1 ln(Total cholesterol) VFA 1.67 0.197
smoking 1.21 0.299
VFA*smoking 0.21 0.812
ln(HDL cholesterol) VFA 60.49 <0.001
smoking 7.24 <0.001
VFA*smoking 1.14 0.320
ln(Triglycerides) VFA 96.52 <0.001
smoking 12.17 <0.001
VFA*smoking 5.53 0.004
Study 2 ln(Glucose) VFA 40.16 <0.001
smoking 0.78 0.461
VFA*smoking 5.75 0.003
ln(HbA1c) VFA 23.54 <0.001
smoking 5.91 0.003
VFA*smoking 4.67 0.010
ANOVA, analysis of variance; HDL, high-density lipoprotein; VFA,
visceral fat area.
Two-way ANOVA was used to evaluate the effects of the interaction
between VFA categories and smoking habits on the natural logarithms
of the serum concentrations of total cholesterol, HDL cholesterol,
triglycerides, glucose, and HbA1c.
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current smokers (P < 0.01) among the subjects with VFA
<100 cm2, whereas in the VFA ≥100 cm2 group, former
smokers displayed a signiﬁcantly lower mean HbA1c level
than current smokers (P < 0.05). The mean serum glucose
level was not associated with smoking habits in either the
VFA <100 cm2 or VFA ≥100 cm2 groups. Energy intake did
not differ among the three smoking habit groups in the
VFA <100 cm2 or VFA ≥100 cm2 group. Current smokers
consumed more alcohol than the other groups.
Figure 3 shows the prevalence of elevated glucose and
HbA1c concentrations. In the VFA <100 cm2 group, serum
HbA1c levels of ≥5.6% were detected in signiﬁcantly higher
proportions of current smokers (17.9%) and former smokers
(14.9%) than non-smokers (6.3%), whereas in the VFA
≥100 cm2 group, serum HbA1c levels of ≥5.6% were observed
in signiﬁcantly greater proportions of current smokers (31.5%)
and non-smokers (29.6%) than former smokers (19.6%).
The relationships of the interaction between VFA and
smoking habits and the subjects’ serum glucose and HbA1c
concentrations are shown in Table 3. Two-way ANCOVA
demonstrated that the interaction between VFA and smoking
habits was signiﬁcantly associated with the subjects’ serum
ln(glucose) (P = 0.003) and ln(HbA1c) levels (P = 0.010).
However, no relationship was detected between the subjects’
smoking habits and their serum glucose levels.
DISCUSSION
Our data showed that both smoking and VF accumulation
were associated with serum TG, HDL-C, and HbA1c
concentrations, and that the interaction between smoking
habits and VFA was also associated with serum TG and
HbA1c levels but not serum HDL-C concentrations. The
former two parameters demonstrated different relationships
with the interaction between smoking habits and VFA, and
the associations between smoking habits and these parameters
differed according to VFA. The ﬁndings of the present study
suggest that smoking is only weakly associated with the serum
TG concentrations among men with little VF. However, in
men with large amounts of VF, the relationship between
smoking and serum TG concentrations might be stronger.
Although smoking might be associated with HbA1c
concentrations in men with little VF, it might not be as
strongly related to HbA1c concentrations as VFA. Moreover,
while the serum HDL-C level might be related to VFA, it may
also be associated with smoking habits, irrespective of the
amount of VF present.
These results suggest that differences in VF accumulation
might have been responsible for the inconsistent results
obtained by previous studies regarding the relationships
between smoking and serum TG or HbA1c levels. Freeman
Table 3. Characteristics of Study 2 subjects according to their smoking habits
All
n = 877
VFA <100 cm2 VFA ≥100 cm2
Non-smokers Former smokers Current smokers Non-smokers Former smokers Current smokers
n = 142 n = 202 n = 196 n = 71 n = 158 n = 108
Age, years 60.3 (10.7) 58.8 (10.9) 61.2 (11.2)* 58.7 (10.7)† 61.9 (9.9) 62.9 (10.1) 59.0 (10.3)††
BMI, kg/m2 23.0 (2.8) 22.0 (2.2) 22.1 (2.3) 21.3 (2.4)*†† 25.2 (2.1) 25.0 (2.3) 25.0 (2.3)
VFA, cm2 91.4 (49.7) 57.3 (24.0) 63.3 (24.1)* 58.4 (25.4)† 135.8 (29.2) 143.6 (39.3) 143.0 (36.6)
Subcutaneous fat area, cm2 111.5 (47.7) 95.1 (36.4) 99.2 (40.0) 87.5 (40.7)†† 141.4 (50.8) 143.5 (43.8) 132.7 (45.7)
Physical activity, METS*min/yr/103 701 (86) 712 (89) 699 (85) 716 (99) 706 (84) 681 (68)* 688 (80)
Glucose, mg/dL 100.3 (12.9) 96.8 (10.4) 100.0 (11.3)** 97.5 (11.1)† 106.8 (21.4) 102.2 (10.9)* 103.4 (14.2)
HbA1c, % 5.22 (0.49) 5.05 (0.40) 5.17 (0.38)* 5.23 (0.46)** 5.40 (0.81) 5.23 (0.38)* 5.39 (0.59)†
n = 816 n = 134 n = 190 n = 179 n = 65 n = 150 n = 98
Energy intake, kcal 2303 (401) 2297 (411) 2309 (371) 2298 (392) 2279 (432) 2282 (366) 2359 (485)
Alcohol intake, g/day 16.1 (19.7) 10.7 (14.3) 15.7 (17.9)* 17.9 (23.2)** 12.3 (15.5) 14.6 (15.8) 25.4 (26.2)**††
BMI, body mass index; METS, metabolic equivalents; VFA, visceral fat area.
Data are shown as mean (standard deviation) values.
The differences between groups were analyzed using the Steel-Dwass test.
P-values: Compared with non-smokers: *P < 0.05, **P < 0.01; Compared with former smokers: †P < 0.05, ††P < 0.01.
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Figure 3. Frequencies of high serum glucose and
hemoglobin A1c concentrations.
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et al3 reported that smoking had little impact on TG. However,
the subjects of this study had a mean BMI of around 25 kg/m2,
so they probably did not have much VF. Some studies have
found that the relationship between smoking and serum
fasting glucose concentrations is stronger in lean men than in
obese men.24,35,36 Our data support these ﬁndings. Henkin
et al9 reported that there was no association between smoking
and insulin sensitivity. The mean BMI of their participants
was 29.4 (standard deviation, 5.9) kg/m2; thus, it is presumed
that most of the participants in their study were overweight
or obese.
The mechanism responsible for the interaction between
smoking habits and VF accumulation is poorly understood,
although it seems to involve lipoprotein lipase (LPL) activity
and certain adipocytokines. For example, the pre-heparin
plasma LPL mass was found to be negatively correlated
with TG concentration and insulin resistance and positively
correlated with HDL-C concentration.37 Increased serum
levels of adiponectin (an adipocytokine) have been found to
be associated with higher HDL-C levels and lower TG38 and
glucose concentrations.39
Abdominal VFA itself is strongly correlated with higher
TG and lower HDL-C levels, as well as with insulin
resistance.12,15–17 VF might release free fatty acids into the
portal circulation, causing them to enter the liver directly, and
excess free fatty acids might enhance hepatic TG synthesis
and insulin resistance.38,40
However, smokers exhibit reduced plasma post-heparin
LPL activity and adiponectin levels,41–43 and both of these
parameters were found to be inversely correlated with VFA.37
We did not measure the serum levels of these substances,
so further investigation of these relationships is required.
In the present study, about 35% of the subjects were
smokers, which was similar to the prevalence obtained in the
2011 National Health and Nutrition Examination Survey
(32.4%).34
Energy balance is associated with body weight and VF
accumulation, and physical activity improves serum lipid
levels and insulin resistance.44,45 However, neither of these
parameters differed among the three smoking habit groups in
the present study. Smokers consumed more alcohol than non-
smokers in both the VFA <100 cm2 and VFA ≥100 cm2 groups
in the present study, and similar ﬁndings were obtained in
previous studies.36,46,47 Alcohol consumption is also positively
associated with serum HDL-C levels in both smokers and
non-smokers,48,49 and excessive alcohol consumption is
associated with higher serum TG concentrations.48,50 In the
present study, we found that controlling for alcohol intake had
little effect on our results (data not shown).
The current study had some limitations. First, we did not
examine the number of cigarettes smoked per day or the
duration since smoking cessation in our analysis, and the
effects of smoking on serum lipid levels and DM2,11 have been
shown to be dose-dependent. The number of years since
smoking cessation has also been shown to be associated with
the risk of DM.51–53 Thus, a longitudinal analysis examining
the effects of the interaction between smoking and VF
accumulation on serum lipid and glucose levels needs to be
performed in the future. Second, passive smokers were not
distinguished from non-smokers. It has been reported that
passive smoking is associated with an increased risk of
coronary heart disease54–56 and type 2 DM,57 and the non-
smoker group in the present study might have included some
passive smokers.
In conclusion, smoking was found to be associated with
higher serum TG, glucose, and HbA1c levels and lower serum
HDL-C levels. The associations between smoking habits and
these parameters differed according to VFA. However, the
interaction between VFA and smoking habits exhibited
different relationships with the serum levels of TG and
HbA1c; VFA had a stronger association with serum HbA1c
level than smoking, and, among subjects with a lot of VF,
elevated serum TG levels were detected in signiﬁcantly
greater proportions of smokers and former smokers than non-
smokers. These ﬁndings suggest that not smoking and not
accumulating VF are both important for health. In particular,
middle-aged and elderly men with a lot of VF should not
smoke or should quit smoking because smoking exhibits a
strong adverse association with serum TG concentration.
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